Page last updated: 2024-10-24

cefuroxime and Abnormality, Heart

cefuroxime has been researched along with Abnormality, Heart in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"The routine dosing regimen provided was sufficient for prophylaxis, but continuous dosing can provide a higher percentage of ƒT > MIC."1.48Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery. ( Gertler, R; Grassin-Delyle, S; Gruber, M; Martin, K; Tassani-Prell, P; Urien, S; Wiesner, G, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gertler, R1
Gruber, M1
Wiesner, G1
Grassin-Delyle, S1
Urien, S1
Tassani-Prell, P1
Martin, K1

Other Studies

1 other study available for cefuroxime and Abnormality, Heart

ArticleYear
Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:9

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiopulmonary Bypass; Cefuroxime; Chromatography, H

2018